ANTONELLI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 6.340
EU - Europa 3.185
AS - Asia 2.855
SA - Sud America 559
AF - Africa 44
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 13.003
Nazione #
US - Stati Uniti d'America 6.226
CN - Cina 1.020
SG - Singapore 1.000
DE - Germania 894
UA - Ucraina 563
PL - Polonia 561
BR - Brasile 492
HK - Hong Kong 294
FI - Finlandia 231
RU - Federazione Russa 231
IT - Italia 198
GB - Regno Unito 152
VN - Vietnam 150
TR - Turchia 139
FR - Francia 100
IE - Irlanda 98
IN - India 86
CA - Canada 60
BE - Belgio 39
MX - Messico 37
BD - Bangladesh 28
AR - Argentina 22
IR - Iran 20
SE - Svezia 19
ZA - Sudafrica 19
CZ - Repubblica Ceca 18
ES - Italia 15
IQ - Iraq 14
NL - Olanda 14
JP - Giappone 13
SA - Arabia Saudita 13
AU - Australia 11
EC - Ecuador 11
ID - Indonesia 11
PK - Pakistan 11
AE - Emirati Arabi Uniti 10
EU - Europa 8
MA - Marocco 8
AT - Austria 7
UZ - Uzbekistan 7
CL - Cile 6
UY - Uruguay 6
VE - Venezuela 6
AZ - Azerbaigian 5
CO - Colombia 5
HU - Ungheria 5
JM - Giamaica 5
MY - Malesia 5
PT - Portogallo 5
PY - Paraguay 5
IL - Israele 4
JO - Giordania 4
KE - Kenya 4
KR - Corea 4
KZ - Kazakistan 4
LT - Lituania 4
MK - Macedonia 4
RO - Romania 4
TN - Tunisia 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
KG - Kirghizistan 3
LV - Lettonia 3
MD - Moldavia 3
NP - Nepal 3
CH - Svizzera 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
PA - Panama 2
PE - Perù 2
TT - Trinidad e Tobago 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SO - Somalia 1
Totale 13.001
Città #
Fairfield 780
Ashburn 698
Woodbridge 577
Warsaw 560
Singapore 449
Jacksonville 447
Houston 373
Seattle 307
Ann Arbor 294
Hong Kong 294
Cambridge 290
Beijing 285
Wilmington 255
Chandler 244
Princeton 190
New York 165
Helsinki 145
Munich 117
Los Angeles 112
Istanbul 107
Nanjing 103
Dublin 98
Dearborn 77
Nürnberg 59
The Dalles 56
Turku 51
Brescia 50
Jinan 48
Nanchang 48
Des Moines 47
São Paulo 46
Ho Chi Minh City 45
Shanghai 45
Buffalo 43
Dallas 43
Shenyang 43
Moscow 41
Redondo Beach 41
Brussels 36
Changsha 33
San Diego 31
Dong Ket 28
Hebei 27
Rio de Janeiro 25
San Mateo 24
Tianjin 24
San Francisco 23
Chicago 22
Jiaxing 22
Monmouth Junction 22
Toronto 22
Frankfurt am Main 21
Washington 21
Hanoi 20
Milan 19
Santa Clara 19
London 18
Ardabil 17
Falkenstein 17
Guangzhou 17
Hangzhou 17
Montreal 17
Düsseldorf 15
Leawood 15
Zhengzhou 15
Denver 14
Johannesburg 14
Kunming 14
Lancaster 14
Hefei 13
Tokyo 13
Verona 13
Augusta 12
Mexico City 12
Orem 12
Phoenix 12
Boardman 11
Brooklyn 11
Lanzhou 11
Orange 11
Atlanta 10
Brno 10
Chennai 10
Curitiba 9
Kocaeli 9
Porto Alegre 9
Rome 9
Stockholm 9
Boston 8
Brasília 8
Da Nang 8
Jakarta 8
Norwalk 8
Poplar 8
Amsterdam 7
Belo Horizonte 7
Campinas 7
Dhaka 7
Manchester 7
Ningbo 7
Totale 8.612
Nome #
Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: Is combination therapy better than monotherapy 275
Laparoscopic and robotic ureteral stenosis repair: a multi-institutional experience with a long-term follow-up 272
Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma 229
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 220
[ProACT (Adjustable Continence Therapy) implants in case of failure of other techniques for urinary incontinence]. 219
Pros-IT CNR: an Italian prostate cancer monitoring project 205
Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years 187
OUTCOMES OF PREVENTIVE VS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING RARP: PRELIMINARY RESULTS OF A RANDOMIZED TRIAL 172
Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic disease 169
Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma 168
DISCRIMINATION ABILITY OF THE SURFACE-INTERMEDIATE-BASE MARGIN (SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 167
Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients 162
Features of Ipsilateral Renal Recurrences After Partial Nephrectomy: A Proposal of a Pathogenetic Classification 161
External histopathological validation of the surface-intermediate-base margin score 161
[Differences in morbidity of neobladder versus ileal conduit: a matched pair analysis on 134 patients] 160
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 159
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 159
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 158
Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma. 157
MP34-09 IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY ON A SINGLE CENTRE COHORT 157
Serum vitamin D and prostate cancer prognosis: The story continues 155
End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline 154
Surgically-induced hypertension and cardiovascular morbidity following treatment for localized kidney cancer: the impact of nephrons loss 154
Features, risk factors and clinical outcome of "very late" recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up 153
A SNAPSHOT OF NEPHRON SPARING SURGERY IN ITALY: A PROSPECTIVE, MULTICENTER REPORT ON CLINICAL AND PERIOPERATIVE OUTCOMES (THE RECORD 1 PROJECT) 153
Comparison of Perioperative Morbidity of Radical Cystectomy with Neobladder Versus Ileal Conduit: A Matched Pair Analysis of 170 Patients 151
A snapshot of nephron-sparing surgery in Italy: A prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project) 149
The R.E.N.A.L. Nephrometric Nomogram Cannot Accurately Predict Malignancy or Aggressiveness of Small Renal Masses Amenable to Partial Nephrectomy. 147
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 147
Holographic Reconstructions for Preoperative Planning before Partial Nephrectomy: A Head-to-Head Comparison with Standard CT Scan 146
A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: The record1 italian project 143
VARIATIONS IN RENAL CORTEX VOLUMES BEFORE AND AFTER PARTIAL NEPHRECTOMY: A PILOT STUDY ON 30 CASES 142
Partial Nephrectomy in Clinical T1b Renal Tumors: Multicenter Comparative Study of Open, Laparoscopic and Robot-assisted Approach (the RECORd Project) 141
Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort. 139
DISCRIMINATION ABILITY OF TH SURFACE-INTERMEDIATE-BASE MARGIN :(SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 139
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 139
A multicentre matched-pair analysis comparing robot-assisted versus open partial nephrectomy. 137
Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function 137
NEPHRON SPARING SURGERY DOES NOT DECREASE OTHER-CAUSES MORTALITY RELATIVE TO RADICAL NEPHRECTOMY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 136
The occurrence of intraoperative complications during partial nephrectomy and their impact on postoperative outcome: results from the RECORd1 project 135
RENAL FUNCTION IMPAIRMENT AFTER NEPHRON SPARING SURGERY OR RADICAL NEPHRECTOMY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 134
The Percentage of Core Involved by Cancer Is the Best Predictor of Insignificant Prostate Cancer, According to an Updated Definition (Tumor Volume up to 2.5 cm(3)): Analysis of a Cohort of 210 Consecutive Patients With Low-risk Disease 134
PIV-03 NEPHRON SPARING TECHNIQUES INDEPENDENTLY REDUCE THE RISK OF CARDIOVASCULAR EVENTS AFTER SURGERY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 134
PROSPECTIVE ANALYSIS OF COMPLICATIONS AND THEIR PREDICTIVE FACTORS AFTER PARTIAL NEPHRECTOMY IN A MULTICENTER COMPARATIVE ITALIAN STUDY (RECORD1) 133
The percentage of core involved by cancer is the best predictor of insignificant prostate cancer, according to an updated definition (tumor volume up to 2.5 cm3): analysis of a cohort of 210 consecutive patients with low-risk disease. 132
Positive surgical margins and early oncological outcomes of robotic versus open radical prostatectomy at a medium case-load institution 132
NEPHRON-SPARING SURGERY PROTECTS FROM CHRONIC KIDNEY DISEASE RELATIVE TO RADICAL NEPHRECTOMY BUT DOES NOT IMPACT ON OTHER-CAUSES MORTALITY: LONG-TERM (MORE THAN 10 YEARS) SURVIVAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH A T1A-T1B RENAL MASS 131
RALP CAN REDUCE THE RATE OF POSITIVE SURGICAL MARGIN: COMPARISON WITH OPEN PROSTATECTOMY IN A MEDIUM VOLUME CENTER 131
Predictive factors of overall and major postoperative complications after partial nephrectomy: Results from a multicenter prospective study (The RECORd 1 project) 128
HOW LONG SHOULD BE EXTENDED FOLLOW UP AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW UP 127
OUTCOMES OF PREVENTIVE VS. DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING RARP: A RANDOMIZED TRIAL 126
Clinical features and prognosis of patients with renal cancer and a second malignancy 124
TriMatch comparison of the efficacy of FloSeal versus TachoSil versus no hemostatic agents for partial nephrectomy: Results from a large multicenter dataset 123
MANAGEMENT AND PROGNOSIS OF POSITIVE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY: RETROSPECTIVE ANALYSIS OF A CONTEMPORARY COHORT 122
PERIOPERATIVE MORBIDITY OF CLAMP VERSUS OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY: PRELIMINARY RESULTS FROM A MULTICENTRE RANDOMIZED CLINICAL TRIAL (THE CLOCK STUDY) 122
PERIOPERATIVE MORBIDITY OF CLAMP VS OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY: PRELIMINARY RESULTS FROM A MULTICENTRE RANDOMIZED CLINICAL TRIAL (THE CLOCK STUDY) 122
Predicting prostate cancer at rebiopsies in patients with high-grade prostatic intraepithelial neoplasia: a study on 546 patients. 121
Prognostic role of tumour multifocality in renal cell carcinoma. 119
IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY 119
Surgical treatment of atypical metastasis from renal cell carcinoma (RCC). 116
HOW LONG SHOULD THE FOLLOW-UP BE EXTENDED AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW-UP 114
Simple enucleation versus standard partial nephrectomy for clinical T1 renal masses: Perioperative outcomes based on a matched-pair comparison of 396 patients (RECORd project). 113
HOW LONG SHOULD BE EXTENDED FOLLOW UP AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW UP 113
OUTCOMES OF A PHASE II I RANDOMIZED CONTROLLED TRIAL COMPARING PREVENTIVE VERSUS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY 113
WIDESPREAD PIN CAN PREDICT THE DIAGNOSIS OF PROSTATE CANCER AFTER A FIRST NEGATIVE RE-BIOPSY 112
ROBOT-ASSISTED PARTIAL NEPHRECTOMYAND BILATERAL PYELOLYTHOTOMY OF ECTOPIC PELVIC KIDNEYS 111
Transformation of prostate adenocarcinoma into small-cell neuroendocrine cancer under androgen deprivation therapy: Much is achieved but more information is needed 111
Cardiopulmonary bypass with brain perfusion for renal cell carcinoma with caval thrombosis 111
HEAD-TO-HEAD EXTERNAL VALIDATION OF RENAL, PADUA, ABC SCORES AND C-INDEX IN NEPHRON SPARING SURGERY 109
ROBOT-ASSISTED RADICAL PROSTATECTOMY: LEARNING-CURVE AND CONTINENCE RATES 109
Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project). 108
Renal Cancer Follow-up Counterpoint: Europe 108
END STAGE RENAL DISEASE AFTER SURGERY IN PATIENTS WITH NORMAL PREOPERATIVE KIDNEY FUNCTION: THE EFFECT OF NEPHRON-SPARING SURGERY IN DELAYING THE ONSET OF THE DISEASE 107
Role of Clinical and Surgical Factors for the Prediction of Immediate, Early and Late Functional Results, and its Relationship with Cardiovascular Outcome after Partial Nephrectomy: Results from the Prospective Multicenter RECORd 1 Project 104
PERIOPERATIVE COMPLICATIONS AFTER PARTIAL NEPHRECTOMY FOR COMPLEX (PADUA SCORE >= 10) RENAL TUMORS: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY (THE RECORD2 PROJECT) 104
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 102
Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project) 101
IMPACT OF GENDER IN NEPHRON-SPARING SURGERY: COMPARISON OF PERIOPERATIVE AND PATHOLOGICAL OUTCOMES FROM THE DEFINITIVE RESULTS OF RECORD1 PROJECT 100
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 100
CHEST FOLLOW-UP SCHEDULE OF SURGICALLY RESECTED RENAL CELL CARCINOMA SHOULD BE DIFFERENTIATED ACCORDING TO HISTOLOGICAL SUBTYPE 99
Prognostic role of delay before radical cystectomy: Retrospective analysis of a single-center cohort with 376 patients 98
External Validation of the Arterial-Based Complexity Score and First Head-to-Head Comparison With the R.E.N.A.L. and PADUA Scores and C-index 96
On-clamp versus off-clamp robotic partial nephrectomy: A systematic review and meta-analysis 95
NEPHRON SPARING TECHNIQUES INDEPENDENTLY REDUCE THE RISK OF CARDIOVASCULAR EVENTS AFTER SURGERY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 94
PD49-06 THE ADHERENCE TO THE EAU GUIDELINES ON PENILE CANCER TREATMENT COULD INFLUENCE THE SURVIVAL: MULTICENTER, RETROSPECTIVE, EUROPEAN STUDY 89
POSITIVE SURGICAL MARGINS PREDICT PROGRESSION-FREE SURVIVAL AFTER NEPHRON SPARING SURGERY FOR RENAL CELL CARCINOMA: RESULTS FROM A SINGLE CENTRE COHORT OF ALMOST 500 CASES WITH A MINIMUM FOLLOW_UP OF 5 YEARS 86
Neoadjuvant androgen deprivation therapy through intense inhibition of the androgen target: "Midsummer Night's Dream" or "Much Ado About Nothing"? 85
Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 85
Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal carcinoma. 83
Tumour contact surface area as a predictor of postoperative complications and renal function in patients undergoing partial nephrectomy for renal tumours 83
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 82
THE ADHERENCE TO THE EAU GUIDELINES ON PENILE CANCER TREATMENT COULD INFLUENCE SURVIVAL: MULTICENTER, RETROSPECTIVE, EUROPEAN STUDY 78
Is off-clamp robot-assisted partial nephrectomy beneficial for renal function? Data from the CLOCK trial 68
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 67
A data-driven approach to refine predictions of differentiated thyroid cancer outcomes: a prospective multicenter study 65
Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis 55
Surgical Experience and Functional Outcomes after Laparoscopic and Robot-Assisted Partial Nephrectomy: Results from a Multi-Institutional Collaboration 55
Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma 54
SURGICAL NOMOGRAM FOR PREDICTING THE LIKELIHOOD OF POSTOPERATIVE SURGICAL COMPLICATIONS IN PATIENTS TREATED WITH PARTIAL NEPHRECTOMY:APROSPECTIVE MULTICENTER OBSERVATIONAL STUDY (THE RECORD 2 PROJECT) 54
A Prospective, Multicenter Study Examining the Relationship between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 54
Totale 12.819
Categoria #
all - tutte 59.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.064 0 0 0 0 0 155 64 170 162 216 210 87
2021/2022771 96 95 19 22 14 44 29 50 47 96 56 203
2022/2023688 100 14 37 43 71 182 0 62 98 4 42 35
2023/2024976 51 19 72 100 58 229 24 48 203 26 9 137
2024/20251.907 13 14 10 272 179 170 148 81 200 153 410 257
2025/20262.257 384 489 280 568 484 52 0 0 0 0 0 0
Totale 13.191